Minimising the consequences of narcolepsy

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Narcolepsy. In: Isselbacher KJ, et al., editors. Harrison’s principles of internal medicine, 13th ed. New York: McGraw-Hill, 1994: 167–8
Aldrich MS. The clinical spectrum of narcolepsy and idiopathic hypersomnia. Neurology 1996 Feb: 46: 393–401
Article PubMed CAS Google Scholar
Aldrich MS. Narcolepsy. N Engl J Med 1990 Aug 9; 323: 389–94
Article PubMed CAS Google Scholar
Hublin C. Narcolepsy: current drug treatment options. CNS Drugs 1996 Jun; 5(6); 426–36
Article CAS Google Scholar
British National Formulary No. 31. London: The Pharmaceutical Press, 1996 Mar: 170–9
Martindale. The Extra Pharmacopoeia, 30th ed. London: Pharmaceutical Press, 1993
Google Scholar
Dictionnarie Vidal 1996. 72nd ed. Paris: OVP Editions du Vidal, 1996: 1016–7
Scharf MB, Brown D, Woods M, et al. The effects and effectiveness of γ-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatry 1985 Jun; 46(6): 222–5
PubMed CAS Google Scholar
T Milter MM, Aldrich MS, Koob GF, et al. Narcolepsy and its treatment with stimulants (ASDA standards of practice). Sleep 1994; 17: 352–71
Google Scholar
Chen SY, Clift SJ, Dahlitz MJ at al. Treatment in the narcoleptic syndrome: self assessment of the action of dexamphetamine and clomipramine. J Sleep Res 1995; 4: 113–8
Article PubMed Google Scholar

Minimising the consequences of narcolepsy. Drugs Ther. Perspect 8, 7–10 (1996). https://doi.org/10.2165/00042310-199608110-00003

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.